Medication strategies: enhancing symptom management and quality of life in palliative care

Rita S. Matos; Fabiana Chyczij; Lília Fernandes; Sara Gonçalves

doi:10.18203/2394-6040.ijcmph20241170

Authors

Rita S. Matos Community Support Team in Palliative Care of the Trás-os-Montes and Alto Douro Local Health Unit, Vila Real, Portugal
Fabiana Chyczij Community Support Team in Palliative Care of the Trás-os-Montes and Alto Douro Local Health Unit, Vila Real, Portugal
Lília Fernandes Community Support Team in Palliative Care of the Trás-os-Montes and Alto Douro Local Health Unit, Vila Real, Portugal
Sara Gonçalves Academic Clinical Center of Trás-os-Montes and Alto Douro - Professor Dr. Nuno Grande-CACTMAD, Vila Real, Portugal

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20241170

Keywords:

Palliative sedation, Cancer, Medication, Patient outcome, End-of-life care

Abstract

Background: Palliative care is integral to addressing suffering during advanced illnesses, and tailored medication is crucial. This study aims to explore medication patterns in palliative care, focusing on understanding their impact on symptom management and patient well-being.

Methods: Data collection involves a retrospective approach with patients referred to the Community Support Team in Palliative Care of the Trás-os-Montes and Alto Douro Local Health Unit between April 2022 and March 2023. Data are recorded, including demographic information, medical history, and pain-related details. Medication is administered based on healthcare professionals’ judgment, following established pain management guidelines. Descriptive and cross-tabulation techniques are employed for the statistical analysis.

Results: Key findings highlight Morphine and Paracetamol as primary analgesics, constituting 14.6% and 13.8%, respectively. Fentanyl, identified as a potent opioid, addresses severe pain at a rate of 10.0%. The study also reveals that 23.7% of cancer patients receive palliative sedation, emphasising its role in symptom control and dignified care.

Conclusions: This research provides significant insights into the intricate relationship between medication administration and palliative care outcomes. The study reveals key findings, such as the prominence of Morphine, Paracetamol, and Fentanyl as essential analgesics in addressing pain and improving patient comfort. Additionally, the high prevalence of palliative sedation among cancer patients underscores its crucial role in symptom control and ensuring dignified care at the end of life. The complexity of medication choices within palliative care settings is emphasised, highlighting the need for careful consideration and tailored approaches.

Metrics

Metrics Loading ...

References

World Health Organization. Palliative care, 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/palliative-care. Accessed 20 December 2023.

Woo JA, Stern TA, Maytal G. Clinical challenges to the delivery of end-of-life care: (rounds in the general hospital). Prim Care Companion J Clin Psych. 2023;08(06):367-72.

Hanefeld J, Powell-Jackson T, Balabanova D. Understanding and measuring quality of care: dealing with complexity. Bull World Health Organ. 2023;95(5):368-74.

Divatia JV, Macaden SC, Muckaden M, Kulkarni P. End-of-life care policy: An integrated care plan for the dying. Ind J Criti Care Medi. 2023;18(9):615-35.

Mierendorf SM, Gidvani V. Palliative Care in the Emergency Department. TPJ. 2024;18(2):77-85.

Narsavage GL, Chen YJ, Korn B, Elk R. The potential of palliative care for patients with respiratory diseases. Breathe. 2017;13(4):278-89.

Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006;15(Suppl 1):S17-24.

Freo U, Ruocco C, Valerio A, Scagnol I, Nisoli E. Paracetamol: a review of guideline recommendations. J Clin Medi. 2021;10(15):3420.

Mestdagh F, Steyaert A, Lavand’homme P. Cancer pain management: a narrative review of current concepts, strategies, and techniques. Curr Oncol. 2023;30(7):6838-58.

Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence. 5th ed. Australian and New Zealand College of Anaesthetists; 2022.

Mandalà M, Moro C, Labianca R, Cremonesi M, Barni S. Optimizing use of opiates in the management of cancer pain. Ther Clin Risk Manag. 2006;2(4):447-53.

Andersen G, Christrup L, Sjøgren P. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update. J Pain Symptom Manag. 2003;25(1):74-91.

Anderson S, Griend J. Quetiapine for insomnia: A review of the literature. AJHP. 2014;71:394-402.

SH, Kanji S, Pereira JL, Davis DHJ, Currow DC, Meagher D, et al. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manag. 2014;48(2):231-48.

Sakamoto R, Koyama A. Effective therapy against severe anxiety caused by cancer: a case report and review of the literature. Cureus. 2020;12(6):e8414.

Benítez-Rosario MA. Fentanyl for episodic dyspnoea in cancer patients. Ann Palliat Medi. 2014;3(1):4-6.

Leppert W. Role of intranasal fentanyl in breakthrough pain management in cancer patients. Cancer Manag. 2010;2:225-32.

Prado BL, Gomes DBD, Usón Júnior PLS, Taranto P, França MS, Eiger D, et al. Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center. BMC Palliative Care. 2018;17(1):13.

Kreye G, Wasl M, Dietz A, Klaffel D, Groselji-Strele A, Eberhard K, et al. Aromatherapy in palliative care: a single-institute retrospective analysis evaluating the effect of lemon oil pads against nausea and vomiting in advanced cancer patients. Cancers. 2022;14(9):2131.